XML 62 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:      
Net income (loss) $ (93,935) $ (131,451) $ (36,092)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Loss from Equity Method Investment in the Joint Venture 56,179 95,732 48,337
Deferred income tax expense (benefit)   (15,806) (11,584)
(Gain) loss on Sale of Interests in the Joint Venture     (661)
(Gain) loss on available for sale debt securities   2,435  
Amortization of debt discount and issuance costs 212 212  
Changes in operating assets and liabilities:      
Prepaid expenses   (2,315)  
Due from the Joint Venture   (972) (62)
Income taxes receivable   179 13,292
Accounts payable and accrued expenses   277 64
Due to McKesson   48,363  
Due to the Joint Venture   3,346 (9,663)
Net cash provided by (used in) operating activities   3,631
Cash flows from investing activities:      
Proceeds from sale of interests in Joint Venture     4,782
Investment in debt and equity securities of the Joint Venture   (278,875)  
Proceeds from investment in debt and equity securities of the Joint Venture   3,621  
Investment in the Joint Venture   (609,818)  
Net cash provided by (used in) investing activities   (885,072) 4,782
Cash flows from financing activities:      
Proceeds from initial public offering, net of issuance costs   608,679  
Proceeds from issuance of equity component of tangible equity units, net of issuance costs   232,929  
Proceeds from issuance of debt component of tangible equity units   47,367  
Payment of loan costs   (1,421)  
Repayment of senior amortizing notes   (3,621)  
Proceeds from exercise of equity awards   1,139  
Payments to acquire common stock     (4,782)
Net cash provided by (used in) financing activities   885,072 (4,782)
Net increase (decrease) in cash, cash equivalents and restricted cash   3,631
Cash, cash equivalents and restricted cash at beginning of period   3,409
Cash, cash equivalents and restricted cash at end of period $ 3,409 $ 3,409 $ 3,631